<SEC-DOCUMENT>0000950170-23-004387.txt : 20230224
<SEC-HEADER>0000950170-23-004387.hdr.sgml : 20230224
<ACCEPTANCE-DATETIME>20230224163113
ACCESSION NUMBER:		0000950170-23-004387
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230224
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230224
DATE AS OF CHANGE:		20230224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		23667902

	BUSINESS ADDRESS:	
		STREET 1:		10170 CHURCH RANCH WAY
		STREET 2:		SUITE 100
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80021
		BUSINESS PHONE:		7209402200

	MAIL ADDRESS:	
		STREET 1:		10170 CHURCH RANCH WAY
		STREET 2:		SUITE 100
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>abio-20230224.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-02-23T17:34:16.9046+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:abio="http://www.arcabiopharma.com/20230224">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_3544f91f-5194-424c-98b3-eba57d5f54af" name="dei:AmendmentFlag" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad">false</ix:nonNumeric><ix:nonNumeric id="F_87fdd172-a0ae-4080-b107-77a966292783" name="dei:EntityCentralIndexKey" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad">0000907654</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="abio-20230224.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000907654</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-24</xbrli:startDate><xbrli:endDate>2023-02-24</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double rgba(0,0,0,1);text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f5e982fd-ecc5-4c91-aad6-ce1865b3b0a8" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_585ddc67-c13e-4d20-ae70-0880a1f960ad" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 24, 2023</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_543b5349-9dae-4c65-b383-6382c44246cd" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:18.0%;"></td>
    <td style="width:41.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_82f1a672-f897-449c-aa9a-5cd645d9d465" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ce0fc359-3ee8-458a-b880-171e096be543" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-22873</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_615b7d5a-122a-4e7c-a641-98cbd029135b" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36-3855489</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or Other Jurisdiction<br />of Incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(IRS Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1825a5ba-8915-4515-b505-568fc94b5c92" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10170 Church Ranch Way</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_bab03fb6-3914-419f-b0f8-467bdedf89fd" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suite 100</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_10bec853-263a-47df-a729-113483223d22" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Westminster</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b5f3837f-dd4b-4f39-a92e-d5a94016546d" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Colorado</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ab57fab2-5fef-4afb-98e6-2a215c8a5b06" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80021</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s Telephone Number, Including Area Code:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d1e51e6f-76e7-42a9-9fd4-0a0d2e2b5232" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(720)</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a7411a85-7b94-4471-a4f4-8938a241d941" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">940-2200</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_71b8f62b-381e-4b20-844c-aef3e728a7d3" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a7cfe532-fb9e-4434-83f5-00f74d2876bf" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_36a84a97-ce61-46b1-9f36-e808074d5502" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0b87c1b5-149b-40a8-ad4a-48daadd02110" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading<br />Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2e39ee08-4bbd-4616-8d45-34a92dd167bd" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ebea9b67-307f-4ab8-819c-5e687b42447e" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ABIO</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d679038d-b2a3-47a9-ac25-ee678f497410" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x202f;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x202f;240.12b-2 of this chapter).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company </span><span style="font-size:10.0pt;"><ix:nonNumeric id="F_d23e5249-a541-4207-b0e1-d4d55c8e6cb1" contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double rgba(0,0,0,1);text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2 &#x2014; Financial Information</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On February 24, 2023, ARCA biopharma, Inc., or ARCA, issued a press release reporting financial results for the year ended December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#x201c;Exchange Act&#x201d;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9 &#x2014; Financial Statements and Exhibits</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11.148%;"></td>
    <td style="width:10.056%;"></td>
    <td style="width:78.796%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="abio-ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Press Release titled &#x201c;ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update&#x201d; dated February 24, 2023</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File. The cover page XBRL tags are embedded within the inline XBRL document (contained in Exhibit 101).</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.0%;"></td>
    <td style="width:44.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:46.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma, Inc.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Registrant)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 24, 2023</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ C. Jeffrey Dekker</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name: C. Jeffrey Dekker <br />Title: Chief Financial Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>abio-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><img src="img123434494_0.jpg" alt="img123434494_0.jpg" style="width:203px;height:69px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">------------------------------------------------------------------------------------------------------------</font><font style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:4.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;" id="ole_link5"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Westminster, CO, February 24, 2023</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#x2013;</font><font id="ole_link6"></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma, Inc.</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported 2022 financial results and provided a corporate update.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2022, the Company retained Ladenburg Thalmann &amp; Co. Inc. to act as its financial advisor to explore and evaluate strategic options for maximizing stockholder value. Potential strategic alternatives that may be explored or evaluated as part of this process include the potential for an acquisition, merger, business combination or other strategic transaction involving the Company. The Board has not set a timetable for the conclusion of this review, nor has it made any decisions related to any further actions or potential strategic options at this time. There can be no assurance, however, that this process will result in any such transaction.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Full Year 2022 Summary Financial Results</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">were $42.4 million as of December 31, 2022, compared to $53.4 million as of December 31, 2021.  ARCA believes that its current cash and cash equivalents, consisting primarily of money market funds, will be sufficient to fund its operations through the middle of 2024.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development (R&amp;D) expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> were $4.7 million for the year ended December 31, 2022, compared to $13.8 million for 2021. In the third quarter of 2022, ARCA implemented a strategic reduction of the workforce and recorded total restructuring charges of approximately $0.8 million, of which $0.5 million and $0.3 million were recognized in research and development and general and administrative expenses, respectively, in connection with the restructuring, all in the form of one-time termination benefits. The $9.1 million decrease in R&amp;D expenses in 2022 as compared to 2021 was primarily related to the completion of enrollment in the rNAPc2 Phase 2b clinical trial in the fourth quarter of 2021, partially offset by the restructuring charges discussed above.  R&amp;D expenses in 2023 are expected to be lower than 2022.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative (G&amp;A) expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> were $5.8 million for the year ended December 31, 2022, compared to $5.5 million for 2021, an increase of approximately $0.3 million. The increase in expenses during 2022 was primarily a result of increases in professional fees and consulting costs and one-time termination benefits discussed above in 2022. G&amp;A expenses in</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023 are expected to be consistent with those in 2022 as the Company maintains administrative activities to support our ongoing operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the year ended December 31, 2022 were $10.6 million compared to $19.3 million in 2021.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the year ended December 31, 2022 was $9.9 million, or $0.69 per basic and diluted share, compared to $19.3 million, or $1.39 per basic and diluted share in 2021.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">About ARCA biopharma</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma is dedicated to developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. At present, ARCA is evaluating options for development of its assets, including partnering and other strategic options. For more information, please visit </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">www.arcabio.com</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or follow the Company on </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LinkedIn</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Safe Harbor Statement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">This press release contains &#34;forward-looking statements&#34; for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding potential future development plans for Gencaro and rNAPc2, if any, the Company&#x2019;s review of strategic options. Such statements are based on management's current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, the risks and uncertainties associated with: ARCA&#x2019;s financial resources and whether they will be sufficient to meet its business objectives and operational requirements; ARCA may not be able to raise sufficient capital on acceptable terms, or at all, to continue development of Gencaro or rNAPc2 or to otherwise continue operations in the future; results of earlier clinical trials may not be confirmed in future clinical trials; the protection and market exclusivity provided by ARCA&#x2019;s intellectual property; risks related to the drug discovery and the regulatory approval processes; the Company&#x2019;s ability to complete a strategic transaction, and, the impact of competitive products and technological changes.  These and other factors are identified and described in more detail in ARCA&#x2019;s filings with the Securities and Exchange Commission, including without limitation ARCA&#x2019;s annual report on Form 10-K for the year ended December 31, 2022, and subsequent filings. ARCA disclaims any intent or obligation to update these forward-looking statements.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investor &amp; Media Contact:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jeff Dekker</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">720.940.2122</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ir@arcabio.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Tables follow)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">###</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA BIOPHARMA, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">BALANCE SHEET DATA</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(unaudited)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">						   </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:52.117%;"></td>
    <td style="width:24.319%;"></td>
    <td style="width:23.564%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$42,445</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$53,359</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Working capital</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$41,567</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$50,923</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$43,085</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$54,924</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stockholders&#x2019; equity</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$41,673</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$51,043</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA BIOPHARMA, INC.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STATEMENTS OF OPERATIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:64.861%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:14.295%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:1.976%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:14.295%;"></td>
    <td style="width:1.004%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Years Ended December 31,</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands, except share<br>and per share amounts)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Costs and expenses:</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,749</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,832</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,847</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,503</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total costs and expenses</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,596</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,335</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(10,596</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(19,335</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest and other income</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">675</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other loss</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(5</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(9,926</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(19,322</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share:</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic and diluted</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(0.69</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1.39</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average shares outstanding:</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic and diluted</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,410,143</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,903,871</font></p></td>
    <td style="background-color:rgba(204,236,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img123434494_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img123434494_0.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #8 GH# 2(  A$! Q$!_\0
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MS2TBOQ._\5?M :UJCO%H\:Z3:]!(0'F8?4\+^'YUYWJ/B#5-88M?:E=79/\
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M"EOAY>+;P/JTOO+=Q)_+-',@Y6?9=%?$$G_!3"+8=G@"7?VW:F /_1=3VO\
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M\(^&]3US49/*L=.MY+J9_144D_RK\:_'GC*]^(7C36O$NHG_ $S5+I[EE_N
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M5IQET8I1ZH^L****T,PHHJKJFJV>AZ;=:AJ%S'9V-K&TT]Q,VU(T49+$^@%
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M> ?C)X7NKV![6[TO6X!<02C:R,LH5U;]17[(GK1'8)[A1115D!1110 4444
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M\9?]<H?_ $<E?E17ZK_MI?\ )M/C+_KE#_Z.2ORHK*6YK'8[WX ?\ER\!?\
M89MO_0Z_8BOQW^ '_)<O 7_89MO_ $.OV(JH$R"BBBK("OSX_P""DVEI;_$;
MPAJ"@;[K2Y8F]?W<N1_Z,-?H/7Y[_P#!2;5%N/B1X2L 1NM=*DE([_O)<?\
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MUC)69M%W1^IO[%OQ,/Q&^!NE17$WFZGH9.EW.XY8A /*8_5"OX@U[Q7YL_\
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MK+5NZ-=$K,^L_P#AH;X8_P#0^:#_ .!R?XT?\-#_  R_Z'S0?_ Y/\:^8?\
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M^+N%.OKEOSK4_P"&%/C-_P!"]8_^#6#_ .*K]2**7*A\S/RSF_8:^,L$9?\
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M[XD^!?[1'Q0O$E\2:-KVJR*<I_:EY&(T/J%W[5_ 5^HM%)QN-2L?EK'^PO\
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M?4?^_P O_P 37J%%>9_J_E7_ $#Q^XZ/KV*_Y^,\P_X9W\,?\]]1_P"_R_\
MQ-'_  SSX8_Y[ZC_ -_E_P#B:]/HH_U?RK_H'C]P?7L5_P _&>8_\,\^&?\
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M>N* LSM:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /GOX_>$7T=8]5;7+V[%[<LHL
M+E]R1@@M\GH!TQCO6+\ ?"O]N>-!?RIFUTQ/.Z<&0\(/YG\*3X^^*O[<\:-8
MQOFUTM/)'/!D/+G^0_"O8?@EX5_X1GP+:O*FV[OS]JER.0"/D'X+C\S65KR-
MKVB=]1116IB%%%% 'G?QW_M0^ +C^S/-QYJ?:O)SN\GG/3G&<9]J\;^ _P#:
M:_$"T_L\2?9=K?;-N?+\O!^]VSG&*^J*B@M8;56$,,<(8Y(C4+D^IQ4N-W<M
M2LK$M%%%40%%%% !1110 4444 %%>(?%3XV:KX;\43:1HHM5CM54332QEV+D
M9('.  ,?K7IGP]U;4M>\'Z;J.K)$E[<IYA$*E1M).TX)X)&#24DW8?*TKG1T
M444Q!4-];F\LY[<2R0&6-D\V$X=,C&Y3V(J:B@#Y.^,'A,^$?$D%L^KW.L--
M#YV^[8M(GS$8)SSTKT7]FKP[Y.GZGK<B8:=Q;0M_LKRQ_$D#\*\I^)GB!O%7
MCK5+R,[X_-^SP#_97Y1CZG)_&OJ3P+X?'A?PCI>FXP\,(\S_ 'SRWZDUE'65
MS:3]VQO4445J8A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR&Q#$WH2/O'V'YUFIJWQ8DT677'73;:WC0S_ -GR18E* 9/';CL3FN9_9_\
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M6ZQ\?/&*W[ 16^E@<BV>V)(';);FO7?!7Q1M=:\ OXAUAH]/%M(T-P5/REP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'/\ COPC%XV\,W>DR2^0TF'CFQG8X.0<=Q_C7A5C\%_'WAW4S-I<D,,H!075
MO=A,J>O7G'X5]*T5+BF4I-'CNA? FXU*^34/&>L2ZQ.O2V61BGT+GG'L *]<
ML[.#3[6*WMHD@MXUVI'&H55'H!4U%-)(3;>X4444Q'*_$[PM=>,O!MYIEE*D
M=RY5T\PX5MK9VD]LUXYX5_9ZU^:^#ZM=)I-J/E?[/+OE=3U QP,^_P"5?1M%
M2XIN[*4FE9&;X?\ #NG^%M+AT_3+9;:UCZ*O5CW9CW)]:TJ**HD*\L^(WPAG
MUK78O$?AZXCL]9C=9'CEX25EZ-GLW'T->IT4FKC3L>->(/#OQ-\>6XT[43IN
MBZ>V!-]GE)\WZX))^F0*Z_X>_"G2? *&:+-[J;KM>\E7! [A!_"/UKMJ*+*]
MPYG:P4444Q'BO[2GB0V^FZ;H<38:X;[3,/\ 87A1^)S_ -\UQ7PQ^&>J>(]&
ME\0:5>K8ZE9W2_8O-'[N0J,MG\2!^!K ^*'B)O%WCO4;F(F2)9/LMN!SE5.T
M8^IR?QKZA\#^'5\*^$],TQ0 \,(\SWD/+'\R:R7O2-G[L4<!J>G?%3Q5:_V?
M<'3-#MG&R:XMY"7=>_0DC\,5TOP]^$^D^ 4\^/-]JC##7DJX('<(/X1^IKMZ
M*TMU,N9[!1113$<+\6O NH^/]&M+*PO(;40S>;(DP.).,#D=,9-/^%?PZ/P[
MT>Y@GN([N\NI!)++&I50 ,*HSZ<_G7;T4K*]QW=K'@WQ0^"NOZ]XNO-5TLPW
MD%X58I)*$>,@ 8YZCBNA\ _!5M,ELK[Q->G5KFT7%K9ER\%N.O?K],8KUBBE
MRJ]Q\SM8****HDR?%6@IXH\.:CI4C^6MU"8P_7:>H/Y@5\\6O[._BN:\\F;[
M';P X-PTVY2/4*!G\\5].T5+BGN4I..QQ?@'X5Z3X#M7,&ZYU&5-DM[(,-SV
M4?PBO&G_ &>?%/\ :[Q(UH+7S"5O#-QMSP=OWL^U?3-%#BF"DT<EX!^'-AX%
MMI'1VOM4G_X^+^?F1_8>B^U=;115;$[A7BOCCX&ZSXR\97FJ/J]K':7#+M#(
MV^-   N.A./>O:J*35]QIM;%72]-@T?3;6QM4V6]O&L2*/0#%6J**8@HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M$=Q,MM!),^=D:EVP,G &3Q7BWCGX\-<:5/::#I=]'+,I0WEU"8Q&#P2J]SZ9
MHHK.<FMC2$4]SQ7P_>QZ'XBTR]O+=YH+>X2:2$C!=0<GK7UKX/\ '^C>.HYW
MTF:21H-OFQR1,A3.<9SP>AZ&BBI@];%S6ESHJ***V, HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
8B@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>abio-20230224.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-23T17:34:16.8873+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.arcabiopharma.com/20230224" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:abio="http://www.arcabiopharma.com/20230224" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20230224_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20230224_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>abio-20230224_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-23T17:34:16.9437+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="abio-20230224.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>abio-20230224_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-23T17:34:16.9231+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139984903043600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 24, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 24,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARCA biopharma, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000907654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">000-22873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-3855489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10170 Church Ranch Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Westminster<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">940-2200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABIO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>abio-20230224_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abio-20230224.xsd" xlink:type="simple"/>
    <context id="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
        </entity>
        <period>
            <startDate>2023-02-24</startDate>
            <endDate>2023-02-24</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_3544f91f-5194-424c-98b3-eba57d5f54af">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_87fdd172-a0ae-4080-b107-77a966292783">0000907654</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_f5e982fd-ecc5-4c91-aad6-ce1865b3b0a8">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_585ddc67-c13e-4d20-ae70-0880a1f960ad">2023-02-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_543b5349-9dae-4c65-b383-6382c44246cd">ARCA biopharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_82f1a672-f897-449c-aa9a-5cd645d9d465">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_ce0fc359-3ee8-458a-b880-171e096be543">000-22873</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_615b7d5a-122a-4e7c-a641-98cbd029135b">36-3855489</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_1825a5ba-8915-4515-b505-568fc94b5c92">10170 Church Ranch Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_bab03fb6-3914-419f-b0f8-467bdedf89fd">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_10bec853-263a-47df-a729-113483223d22">Westminster</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_b5f3837f-dd4b-4f39-a92e-d5a94016546d">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_ab57fab2-5fef-4afb-98e6-2a215c8a5b06">80021</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_d1e51e6f-76e7-42a9-9fd4-0a0d2e2b5232">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_a7411a85-7b94-4471-a4f4-8938a241d941">940-2200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_71b8f62b-381e-4b20-844c-aef3e728a7d3">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_a7cfe532-fb9e-4434-83f5-00f74d2876bf">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_36a84a97-ce61-46b1-9f36-e808074d5502">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_0b87c1b5-149b-40a8-ad4a-48daadd02110">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_2e39ee08-4bbd-4616-8d45-34a92dd167bd">Common</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_ebea9b67-307f-4ab8-819c-5e687b42447e">ABIO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_d679038d-b2a3-47a9-ac25-ee678f497410">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad"
      id="F_d23e5249-a541-4207-b0e1-d4d55c8e6cb1">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .6#6%8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #E@UA6Y9LW>^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)TEE#Z&;B^))07!!\1:2V=U@TX9DI-VW-ZV[740?P&-F_GSS
M#4QKH[)#PN<T1$SD,=],H>NSLG'+CD11 61[Q&!R71)]:>Z'% R59SI -/;#
M'! DYQL(2,89,C #J[@2F6Z=53:AH2&=\<ZN^/B9N@7F+&"' 7O*(&H!3,\3
MXVGJ6K@"9AAA"OF[@&XE+M4_L4L'V#DY9;^FQG&LQV;)E1T$O#T]OBSK5K[/
M9'J+Y5?VBDX1M^PR^;6YN]\],"VY;"HN*WF[DT(U0O'-^^SZP^\J' ;G]_X?
M&U\$=0N_[D)_ 5!+ P04    " #E@UA6F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M .6#6%8F=_OZ8@0  "41   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AM;^)&$,>_RLJ5JCLIB>WE,2D@.2371G>7T$ ;J55?+/:"5V=[W=UU"-^^
MLP9LDIHQO  _S=\_SX[_L\MH(]4/'7-NR%N:9'KLQ,;D-ZZKPYBG3%_)G&=P
M9B55R@SLJK6K<\595 :EB4L]K^^F3&3.9%0>FZG)2!8F$1F?*:*+-&5J>\L3
MN1D[OG,X\"S6L;$'W,DH9VL^Y^:/?*9@SZU4(I'R3 N9$<578R?P;VYISP:4
M5_PI^$8?;1/[*$LI?]B=AVCL>):()SPT5H+!SRN?\B2Q2L#Q[U[4J>YI X^W
M#^I?RH>'AUDRS:<R>1&1B<?.T"$17[$B,<]R\QO?/U )&,I$E]]DL[NVVW5(
M6&@CTWTP$*0BV_VRMWTBC@)HYT0 W0?0DGMWHY+RCADV&2FY(<I>#6IVHWS4
M,AK@1&9'96X4G!409R9W,BP@R88$643N,R/,ECQDN]&&K(U< S>QE[KA7O!V
M)TA/"'[ARRM"NQ>$>K3S/MP%M@J05H"TU.N<T)O*5Z[(W\%2&P5#^$\3T4ZA
MVZQ@Z_I&YRSD8P<*5W/URIW)SS_Y?>\7A*]3\74P]3J!BVW.F^#P\.'E5P2B
M6T%T494 "**2XDO"UDT4>/R*)9HC'+V*HW=>,F9<"6D+*B)0EHUYP96J,FJK
MHWZ%UD<%][7]S-?"5A(P/K*T$0S7"9ZG 5D*F<<,WI$+>%G"*P1O4.$-SL&;
M0O(42T UXF_D*]\V >)*'GRNO4&_UT6PAA76\!RL^Y2KM<C6Y%>(-S&9RC1G
M62,<KM=6:-<5US6J,^=AH8017),@A*H7"2>/1;KDJHD)UX)\75(Z'&!5YGNU
MGWKG9 S*0JI<JM)%+\C<P%M I(+,%3#",- R:BR^%O6[>PSRR/3]<R 7[(T\
M1%!R8B7"DA1)8HMDIW_9&?9ZW>$U1EB[OH^:]H$PB"*P;'UQV"#?X#KRE#7G
M#I?T/7_@D6E<J# FSRR#[Q>VQ6CK'N#C+H[2+C:RD1:7G!<"*L;W/ RP[@\^
M;O ? :=V#\IQ(3?-/1Z7>^':P&1$FX^E\AZO;AL^[O8?\:K79:;DJ\C"YN'&
M-:=/&%K=-ORS^D:%-I/:@$'_)?+3[S"N./0\ZF-L=<_P<:LO1S& R?AI%%S@
MTX!ZGS&4ND_XN+%_DR%D91;+##/B%I'KKG5BO.3K#N'CMOX"_<'PS/:JM,CV
M_J8;J7"AMIY%Z]Y <?>>RT2$T+6@D7Z' E>")8W365REE:=N Q3W[)GBER&D
MA\,;MIO#PC029MM/JU7S^+7HM9(=3?IQK_X?V8/6!9"U N*RK8"UXU/<GA?"
MP)1#KHA//RT_D_U\I'%&U*)DZ_/C0NL]5.WR%+?EA6*1+:[Y-EW*YM)J64?<
M/F"N26M#I[CY'O)![M_"F&5K?G*VW2+T&,SO@M^;F-RC1:_] ^$[LU-431*^
M B7O:@#":K<FW^T8F9?KX*4TL*HN-V/.H)SL!7!^):4Y[-BE=?7/R.0_4$L#
M!!0    ( .6#6%:?H!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;
M,!#^*T(_8&YB:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VA
MR=T]NKM'=R>9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;
M)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/
M3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O
M_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_
M/LG>V)+;.<V"3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:
M^*VZBMU7)/3B4PEM(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_
M[XSC]Y97HA_TOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!
M6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<
M'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72
M[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'
M')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^
M6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]
M?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1
M/,<0F,7XC&894IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\E
MTWLJ.?]74_P$4$L#!!0    ( .6#6%:7BKL<P    !,"   +    7W)E;',O
M+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +
M&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P
M6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,
M-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4
M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ Y8-85CJJHN=  0  / (   \
M  !X;"]W;W)K8F]O:RYX;6R-45UKPS ,_"O&/V!)RU98:09CW4=A;&4=?7=B
MI1&UK6"K[=9?/R4AK+"7/<DZB=/=>7&BN"^)]NK+NY *W3"W\RQ+50/>I"MJ
M(<BDIN@-2QMW66HC&)L: /8NF^;Y+/,&@[Y;C%SKF%TVQ% Q4A"P [8(I_0[
M[UIUQ(0E.N3O0O=O!UIY#.CQ#+;0N5:IH=,+13Q38.,V523G"CT9!EN(C-4?
M>-.)_#1EZA$VY8<1(86>Y4)88TS<;_3\1C0>09:'[L#TA(XA+@W#<Z1#BV'7
MT8B+[,)&G\-8AQ#G\3\Q4EUC!4NJ#AX"#SE&<)W D!ILDU;!>"CTN*+N@U6/
M@24DM0H#E>QV3N7TR@ZN6>1>9!CG*(.XLH/P4:V%&@/8-SF0!)?DJG547>EY
MIM<WDUM)Z.#<@V#OX96,'<V/'W?W U!+ P04    " #E@UA6)!Z;HJT   #X
M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .6#6%;EFS=[[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( .6#
M6%:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ Y8-85B9W^_IB!   )1$  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .6#
M6%:?H!OPL0(  .(,   -              "  :4,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ Y8-85I>*NQS     $P(   L              ( !@0\
M %]R96QS+RYR96QS4$L! A0#%     @ Y8-85CJJHN=  0  / (   \
M         ( !:A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .6#6%8D
M'INBK0   /@!   :              "  =<1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( .6#6%9ED'F2&0$  ,\#   3
M      "  ;P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
'  84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="abio-20230224.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="abio-20230224.htm">abio-20230224.htm</File>
    <File>abio-20230224.xsd</File>
    <File>abio-20230224_lab.xml</File>
    <File>abio-20230224_pre.xml</File>
    <File>abio-ex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "abio-20230224.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "abio-20230224.htm"
     ]
    },
    "labelLink": {
     "local": [
      "abio-20230224_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abio-20230224_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "abio-20230224.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "abio",
   "nsuri": "http://www.arcabiopharma.com/20230224",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "abio-20230224.htm",
      "contextRef": "C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "abio-20230224.htm",
      "contextRef": "C_817bbf10-b5d8-4a10-99ff-c8566a4c0fad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000950170-23-004387-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-004387-xbrl.zip
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M8<=/V.3C/PX[@WP8??Q_4$L#!!0    ( .6#6%:X=L7D$@,  +,)   1
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M8;U;<&MR!)A1GE7\Z;C[L ["6J'O5[NTT8.M;06=W6XDS4US^0=02P,$%
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MK45 I^#Y<9T&[C+T?C"G]S)'[Q-+[P,8FC\G^*DA^-6=,/P'W'CIE>8B)G\
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MA6_^'U!+ 0(4 Q0    ( .6#6%9]7KQ(O1,  !+D   1              "
M 0    !A8FEO+3(P,C,P,C(T+FAT;5!+ 0(4 Q0    ( .6#6%:X=L7D$@,
M +,)   1              "  >P3  !A8FEO+3(P,C,P,C(T+GAS9%!+ 0(4
M Q0    ( .6#6%;$W^-"M@4  "\T   5              "  2T7  !A8FEO
M+3(P,C,P,C(T7VQA8BYX;6Q02P$"% ,4    " #E@UA6.W>"6I@$  !\)@
M%0              @ $6'0  86)I;RTR,#(S,#(R-%]P<F4N>&UL4$L! A0#
M%     @ Y8-85KB:]HL,$P  !U0!  \              ( !X2$  &%B:6\M
@97@Y.5\Q+FAT;5!+!08     !0 % $$!   :-0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
